Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01413
|
|||||
| Drug Name |
Beta-Acetyldigoxin
|
|||||
| Synonyms |
Novodigal (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Cardiovascular disorder [ICD11: BA00-BE2Z] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C43H66O15
|
|||||
| Canonical SMILES |
CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC(=O)C)O)O
|
|||||
| InChI |
InChI=1S/C43H66O15/c1-20-38(55-23(4)44)30(45)17-36(53-20)57-40-22(3)54-37(18-32(40)47)58-39-21(2)52-35(16-31(39)46)56-26-9-11-41(5)25(14-26)7-8-28-29(41)15-33(48)42(6)27(10-12-43(28,42)50)24-13-34(49)51-19-24/h13,20-22,25-33,35-40,45-48,50H,7-12,14-19H2,1-6H3/t20-,21-,22-,25-,26+,27-,28-,29+,30+,31+,32+,33-,35+,36+,37+,38-,39-,40-,41+,42+,43+/m1/s1
|
|||||
| InChIKey |
NREAGDHHMSOWKZ-DXJNJSHLSA-N
|
|||||
| CAS Number |
CAS 5355-48-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 823 | Topological Polar Surface Area | 209 | ||
| Heavy Atom Count | 58 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 15 | |||
| XLogP |
1.8
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
CHEBI:135892
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | National Center for Advancing Translational Science-Inxight: drug (P7K44M64CW) | |||||
| 2 | P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin. Naunyn Schmiedebergs Arch Pharmacol. 2001 Mar;363(3):337-43. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.